Antinociceptive effects of high dose remifentanil in male methadone-maintained patients

European Journal of Pain

Volumn 12, Issue 7, 2008, Pages 926-933

  Hay, Justin L ^a   White, Jason M ^a,b   Bochner, Felix ^a,c   Somogyi, Andrew A ^a,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Drug & Alcohol Services South Australia   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Antinociception; Cold pressor test; Methadone maintenance; Pain; Remifentanil

Indexed keywords

METHADONE; MU OPIATE RECEPTOR AGONIST; REMIFENTANIL;

ADULT; AGED; ANALGESIA; ANTINOCICEPTION; ARTICLE; BREATHING RATE; CHRONIC PAIN; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTROLLED STUDY; DOSE RESPONSE; DROWSINESS; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG TOLERABILITY; HUMAN; HYPOXEMIA; MALE; NAUSEA; NOCICEPTION; PRIORITY JOURNAL; RATING SCALE; SEDATION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VOMITING;

ADULT; ANALGESICS, OPIOID; COLD; DRUG INTERACTIONS; DRUG TOLERANCE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHADONE; OPIOID-RELATED DISORDERS; PAIN; PAIN MEASUREMENT; PIPERIDINES;

EID: 48349100339     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2007.12.012     Document Type: Article

References (38)

1. Adams J.U., Paronis C.A., and Holtzman S.G. Assessment of relative intrinsic activity of μ-opioid analgesics in vivo by using beta-funaltrexamine. J Pharmacol Exp Ther 255 (1990) 1027-1032
2. Alford D.P., Compton P., and Samet J.H. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Int Med 144 (2006) 127-134
3. Angst M.S., and Clark J.D. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104 (2006) 570-587
4. Athanasos P., Smith C.S., White J.M., Somogyi A.A., Bochner F., and Ling W. Methadone-maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations. Pain 120 (2006) 267-275
5. Barrett A.C., Smith E.S., and Picker M.J. Use of irreversible antagonists to determine the relative efficacy of μ-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox. J Pharmacol Exp Ther 305 (2003) 1061-1070
6. Baylon G.J., Kaplan H.L., Somer G., Busto U.E., and Sellers E.M. Comparative abuse liability of intravenously administered remifentanil and fentanyl. J Clin Psychopharmacol 20 (2000) 597-606
7. Black M.L., Hill J.L., and Zacny J.P. Behavioral and physiological effects of remifentanil and alfentanil in healthy volunteers. Anesthesiology 90 (1999) 718-726
8. Borgland S.L., Connor M., Osborne P.B., Furness J.B., and Christie M.J. Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of μ-opioid receptors. J Biol Chem 278 (2003) 18776-18784
9. Bowdle T.A., Camporesi E.M., Maysick L., Hogue Jr. C.W., Miguel R.V., Pitts M., et al. A multicenter evaluation of remifentanil for early postoperative analgesia. Anesth Analg 83 (1996) 1292-1297
10. Calderón E., Pernia A., De Antonio P., Calderón-Pla E., and Torres L.M. A comparison of two constant-dose continuous infusions of remifentanil for severe postoperative pain. Anesth Analg 92 (2001) 715-719
11. Chu L.F., Clark D.J., and Angst M.S. Opioid-tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 7 (2006) 43-48
12. Coller J.K., Barratt D.T., Dahlen K., Loennechen M.H., and Somogyi A.A. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals. Clin Pharmacol Ther 80 (2006) 682-690
13. Davis J.J., Johnson K.B., Egan T.D., Vezina D.P., Snell T.E., and Swenson J.D. Preoperative fentanyl infusion with pharmacokinetic simulation for anesthetic and perioperative management of an opioid-tolerant patient. Anesth Analg 97 (2003) 1661-1662
14. de Leon-Casasola O.A., and Lema M.J. Epidural bupivacaine/sufentanil therapy for postoperative pain control in patients tolerant to opioid and unresponsive to epidural bupivacaine/morphine. Anesthesiology 80 (1994) 303-309
15. Del Favero A., Tonato M., and Roila F. Issues in the measurement of nausea. Br J Cancer Suppl 19 (1992) S69-S71
16. Doverty M., White J.M., Somogyi A.A., Bochner F., Ali R., and Ling W. Hyperalgesic responses in methadone-maintenance patients. Pain 90 (2001) 91-96
17. Doverty M., Somogyi A.A., White J.M., Bochner F., Beare C.H., Menelaou A., et al. Methadone-maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 93 (2001) 155-163
18. Egan T.D., Lemmens H.J., Fiset P., Hermann D.J., Muir K.T., Stanski D.R., et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 79 (1993) 881-892
19. Glass P.S., Hardman D., Kamiyama Y., Quill T.J., Marton G., Donn K.H., et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 77 (1993) 1031-1040
20. Haertzen C., and Hickey J. Addiction research centre inventory (ARCI): measurement of euphoria and other drug effects. In: Bozarth M.A. (Ed). Methods of assessing the reinforcing properties of abused drugs (1987), Springer Verlag, New York
21. Handelsman L., Cochrane K.J., Aronson M.J., Ness R., Rubinstein K.J., and Kanof P.D. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 13 (1987) 293-308
22. Hsu Y.W., Cortinez L.I., Robertson K.M., Keifer J.C., Sum-Ping S.T., Moretti E.W., et al. Dexmedetomidine pharmacodynamics: Part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 101 (2004) 1066-1076
23. Jage J., and Bey T. Postoperative analgesia in patients with substance use disorders: Part I. Acute Pain 3 (2000) 29-44
24. James M.K., Feldman P.L., Schuster S.V., Bilotta J.M., Brackeen M.F., and Leighton H.J. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 259 (1991) 712-718
25. Kantor T.G., Cantor R., and Tom E. A study of hospitalized surgical patients on methadone-maintenance. Drug Alcohol Depen 6 (1980) 163-173
26. Kristensen K., Christensen C.B., and Christrup L.L. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Science 56 (1995) 45-50
27. Kucukemre F., Kunt N., Kaygusuz K., Kiliccioglu F., Gurelik B., and Cetin A. Remifentanil compared with morphine for postoperative patient-controlled analgesia after major abdominal surgery: a randomized controlled trial. Eur J Anaesthesiol 22 (2005) 378-385
28. Manfredi P.L., Gonzales G.R., Cheville A.L., Kornick C., and Payne R. Methadone analgesia in cancer pain patients on chronic methadone-maintenance therapy. J Pain Sympt Manage 21 (2001) 169-174
29. Portenoy R.K., Dole V., Joseph H., Lowinson J., Rice C., Segal S., et al. Pain management and chemical dependency. Evolving perspectives. J Am Med Assoc 278 (1997) 592-593
30. Rapp S.E., Ready L.B., and Nessly M.L. Acute pain management in patients with prior opioid consumption: a case-controlled retrospective review. Pain 61 (1995) 195-201
31. Ready L.B., Oden R., Chadwick H.S., Benedetti C., Rooke G.A., Caplan R., et al. Development of an anesthesiology-based postoperative pain management service. Anesthesiology 68 (1988) 100-106
32. Schüttler J., Albrecht S., Breivik H., Osnes S., Prys-Roberts C., Holder K., et al. A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 52 (1997) 307-317
33. Scimeca M.M., Savage S.R., Portenoy R., and Lowinson J. Treatment of pain in methadone-maintained patients. Mt Sinai J Med 67 (2000) 412-422
34. Selley D.E., Liu Q., and Childers S.R. Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus. J Pharmacol Exp Ther 285 (1998) 496-505
35. Stevens C.W., Klopp A.J., and Facello J.A. Analgesic potency of mu and kappa opioids after systemic administration in amphibians. J Pharmacol Exp Ther 269 (1994) 1086-1093
36. Vinik H.R., and Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 86 (1998) 1307-1311
37. Westmoreland C.L., Hoke J.F., Sebel P.S., Hug Jr. C.C., and Muir K.T. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 79 (1993) 893-903
38. Yarmush J., D'Angelo R., Kirkhart B., O'Leary C., Pitts II M.C., Graf G., et al. A comparison of remifentanil and morphine sulfate for acute postoperative analgesia after total intravenous anesthesia with remifentanil and propofol. Anesthesiology 87 (1997) 235-243